Оцінка Терапевтичної Активності Метилурацилу Вітчизняного Виробництва Порівняно З Імпортним Аналогом
Year: 2025
Type: article
Abstract: Wound-healing agents are an important component of complex therapy for mechanical, thermal, and chemical injuries of the skin and mucous membranes. Among them, methyluracil occupies a leading position due to its pronounced reparative, anti-inflammatory, and immunostimulating activity. Its pharmacological effect is linked to the stimulation of nucleic acid production, enhancement of epithelial cell and fibroblast proliferation, as well as the promotion of granulation tissue development and epithelialization. On the Ukrainian pharmaceutical market, there are both domestic and imported preparations of methyluracil; however, differences in synthesis technology and purification degree may determine variations in clinical efficacy. The objective of this study was to evaluate and compare the wound-healing effects of methyluracil obtained from two different production sources (India and Ukraine) using a full-thickness stencil wound еxperimental wound model using rats. The experiment was carried out on 24 rats, which were allocated into 4 groups of 6 animals each: Group I – control pathology; Group II – animals treated with the test sample (TS) of methyluracil produced in Ukraine; Group III – animals treated with TS Methyluracil (India); Group IV (comparison group) – animals treated with “Levomekol” ointment. Effectiveness was assessed by wound healing dynamics, lesion area, repair rate, and the percentage of animals with complete healing. Prior to the experiment, the animals underwent a 7-day acclimatization period. Animal care complied with GLP principles and relevant recommendations. Healing of experimental wounds in animals was accompanied by a typical inflammatory response manifested by hyperemia and edema during the first days. In the control group, on day 3, intense exudate secretion with signs of secondary infection was observed. Scarring in control animals occurred between days 15–21. The results showed that application of the test samples of methyluracil (India and Ukraine) ensured earlier onset of granulation tissue formation and epithelialization compared to the control and reference groups. In the methyluracil-treated groups (India and Ukraine), scarring was observed between days 6–11, with complete epithelialization in 100 % of animals by day 18. Meanwhile, in the comparison group (treated with Levomekol ointment), scarring started on day 11, and complete epithelialization was achieved by day 18. Thus, the use of TS Methyluracil (India) and TS Methyluracil (Ukraine) ensured an earlier onset of reparative processes compared to both the control and reference groups. Surgical wound application and anesthesia did not cause animal deaths. However, stress and pain reaction led to temporary appetite loss, resulting in body weight reduction after 7 days. By day 14, however, all groups demonstrated positive weight gain, with no significant intergroup differences. The study confirmed that methyluracil (India and Ukraine) in a full-thickness stencil wound rat model exhibited a pronounced wound-healing effect. Its use contributed to suppression of the inflammatory response, reduction of infection risk, and accelerated wound defect closure, justifying the feasibility of further pharmacological studies.
Source: Art of Medicine
Institution: National University of Pharmacy
Language: Ukrainian
Topic: Wound Healing and Treatments
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7117123743
